[Six-month real-world outcomes of intravitreal clindamycin for ocular toxoplasmosis].
Roubelat FP, Varenne F, Gualino V, Pugnet G, Civade E, Bataille N, Bruzard H, Barioulet L, Adam R, Fournié P, Soler V.
Roubelat FP, et al. Among authors: soler v.
J Fr Ophtalmol. 2024 Dec 18;48(1):104387. doi: 10.1016/j.jfo.2024.104387. Online ahead of print.
J Fr Ophtalmol. 2024.
PMID: 39700782
Free article.
French.